Inventor · disambiguated record
Hans Lilja
Also filed as: LILJA HANS
18 granted patents·6 pending applications·356 citations·filing 1991–2023
95Inventor score
Top patents by PatentIndex Score
24 records- 0194US6265540B1Tissue specific prodrugUNIV JOHNS HOPKINS MED·Filed 1998·Granted Jul 24, 2001·78 cites·17 claims
- 0289US9672329B2Methods and apparatuses for predicting risk of prostate cancer and prostate gland volumeOY ARCTIC PARTNERS AB·Filed 2013·Granted Jun 6, 2017·13 cites·13 claims
- 0389US6504014B1Tissue specific prodrugUNIV JOHNS HOPKINS·Filed 2000·Granted Jan 7, 2003·30 cites·14 claims
- 0489US6410514B1Tissue specific prodrugUNIV JOHNS HOPKINS·Filed 2000·Granted Jun 25, 2002·23 cites·33 claims
- 0589US5501983AAssay of free and complexed prostate-specific antigenFiled 1991·Granted Mar 26, 1996·65 cites·20 claims
- 0688US10672503B2Methods and apparatuses for conducting analysesOPKO DIAGNOSTICS LLC·Filed 2016·Granted Jun 2, 2020·3 cites·18 claims
- 0788US7053042B1Activation of peptide prodrugs by hK2DENMEADE SAMUEL R·Filed 2000·Granted May 30, 2006·20 cites·40 claims
- 0886US11761962B2Compositions and methods related to diagnosis of prostate cancerOPKO DIAGNOSTICS LLC·Filed 2015·Granted Sep 19, 2023·3 cites·16 claims
- 0985US12131802B2Methods and apparatuses for predicting risk of prostate cancer and prostate gland volumeOPKO DIAGNOSTICS LLC·Filed 2017·Granted Oct 29, 2024·2 cites·16 claims
- 1082US5939533AAssay of free and complexed prostate-specific antigen (PSA)Filed 1995·Granted Aug 17, 1999·47 cites·17 claims
- 1178US7906477B2Activation of peptide prodrugs by hK2GENSPERA INC·Filed 2003·Granted Mar 15, 2011·4 cites·28 claims
- 1277US2023393137A1Compositions and methods related to diagnosis of prostate cancerOPKO DIAGNOSTICS LLC·Filed 2023·Application pending·0 cites
- 1370US2022399121A1Systems for providing a probability of prostate cancer risk and/or prostate gland volume, and related methodsOPKO DIAGNOSTICS LLC·Filed 2022·Application pending·0 cites
- 1469US7872104B2Antibody, immunoassay and method for prostate cancer detectionARCTIC PARTNERS OY AB·Filed 2001·Granted Jan 18, 2011·14 cites·6 claims
- 1564US5614372AEarly detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)Filed 1995·Granted Mar 25, 1997·38 cites·35 claims
- 1659US2008247950A1Activation of peptide prodrugs by hK2GENSPERA INC·Filed 2007·Application pending·0 cites
- 1758US8669231B2Activation of peptide prodrugs by hK2DENMEADE SAMUEL R·Filed 2011·Granted Mar 11, 2014·0 cites·7 claims
- 1856US8450280B2Activation of peptide prodrugs by hK2DENMEADE SAMUEL R·Filed 2012·Granted May 28, 2013·0 cites·19 claims
- 1955US2006183689A1Activation of peptide prodrugs by hK2DENMEADE SAMUEL R·Filed 2005·Application pending·0 cites
- 2053US2016320394A1Compositions and methods for active surveillance of prostate cancerOPKO DIAGNOSTICS LLC·Filed 2016·Application pending·0 cites
- 2146US2002123616A1Prostate specific antigen (PSA) -proteinase inhibitors complexesFiled 2001·Application pending·0 cites
- 2243US6143509AProstate specific antigen peptides and uses thereofABBOTT LAB·Filed 1996·Granted Nov 7, 2000·12 cites·15 claims
- 2338US12326453B2Compositions and methods for active surveillance of prostate cancerOPKO DIAGNOSTICS LLC·Filed 2016·Granted Jun 10, 2025·0 cites·3 claims
- 2437US5912158AProstate specific antigen (PSA)-proteinase inhibitor complexesFiled 1995·Granted Jun 15, 1999·4 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →